ARSI
Basic information
Region (hg38): 5:150296343-150339307
Links
Phenotypes
GenCC
Source:
- autosomal recessive spastic paraplegia type 66 (Supportive), mode of inheritance: AR
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ARSI gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 29 | 12 | 41 | |||
missense | 84 | 87 | ||||
nonsense | 7 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 92 | 32 | 13 |
Variants in ARSI
This is a list of pathogenic ClinVar variants found in the ARSI region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
5-150297252-G-A | Spastic paraplegia | Uncertain significance (Feb 19, 2020) | ||
5-150297264-G-A | Spastic paraplegia | Uncertain significance (Sep 15, 2022) | ||
5-150297280-G-A | Spastic paraplegia | Likely benign (Jul 12, 2022) | ||
5-150297282-A-AT | Uncertain significance (Jan 31, 2014) | |||
5-150297293-C-T | Spastic paraplegia • not specified | Uncertain significance (Jul 12, 2023) | ||
5-150297296-C-T | Spastic paraplegia • not specified | Uncertain significance (Jul 05, 2023) | ||
5-150297297-G-A | not specified | Uncertain significance (Mar 06, 2023) | ||
5-150297303-G-A | Spastic paraplegia | Uncertain significance (Feb 27, 2022) | ||
5-150297314-C-T | Spastic paraplegia | Uncertain significance (Sep 22, 2019) | ||
5-150297330-C-T | Spastic paraplegia | Uncertain significance (May 08, 2023) | ||
5-150297346-A-G | Spastic paraplegia | Likely benign (Jul 22, 2023) | ||
5-150297349-A-G | Spastic paraplegia | Likely benign (Nov 15, 2022) | ||
5-150297350-C-T | Spastic paraplegia | Uncertain significance (Jun 20, 2022) | ||
5-150297353-G-A | Spastic paraplegia | Uncertain significance (Jan 30, 2024) | ||
5-150297380-A-C | Spastic paraplegia | Uncertain significance (Jan 18, 2024) | ||
5-150297383-T-C | Spastic paraplegia | Uncertain significance (Apr 25, 2018) | ||
5-150297396-G-A | Spastic paraplegia | Uncertain significance (Feb 01, 2022) | ||
5-150297422-G-A | Spastic paraplegia | Uncertain significance (Nov 08, 2017) | ||
5-150297434-C-T | Spastic paraplegia | Uncertain significance (Dec 11, 2019) | ||
5-150297435-G-C | Spastic paraplegia | Uncertain significance (Aug 21, 2018) | ||
5-150297444-C-A | Spastic paraplegia | Uncertain significance (Nov 04, 2017) | ||
5-150297468-G-A | Hereditary spastic paraplegia | Uncertain significance (Mar 07, 2017) | ||
5-150297483-G-A | Spastic paraplegia | Uncertain significance (Jun 29, 2021) | ||
5-150297503-C-G | Spastic paraplegia | Uncertain significance (Jul 06, 2022) | ||
5-150297503-C-T | Spastic paraplegia • not specified | Uncertain significance (Sep 09, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ARSI | protein_coding | protein_coding | ENST00000328668 | 2 | 42965 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
5.96e-15 | 0.0150 | 125662 | 0 | 86 | 125748 | 0.000342 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.853 | 339 | 386 | 0.878 | 0.0000262 | 3667 |
Missense in Polyphen | 136 | 166.02 | 0.81915 | 1655 | ||
Synonymous | 0.210 | 154 | 157 | 0.979 | 0.0000102 | 1202 |
Loss of Function | 0.0423 | 22 | 22.2 | 0.990 | 0.00000129 | 196 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000463 | 0.000460 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000599 | 0.000598 |
Finnish | 0.000233 | 0.000231 |
European (Non-Finnish) | 0.000288 | 0.000281 |
Middle Eastern | 0.000599 | 0.000598 |
South Asian | 0.000988 | 0.000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Displays arylsulfatase activity at neutral pH, when co- expressed with SUMF1; arylsulfatase activity is measured in the secretion medium of retinal cell line, but no activity is recorded when measured in cell extracts. {ECO:0000269|PubMed:16500042, ECO:0000269|PubMed:19262745}.;
- Pathway
- Metabolism of lipids;Post-translational protein modification;Metabolism of proteins;The activation of arylsulfatases;Gamma carboxylation, hypusine formation and arylsulfatase activation;Metabolism;Glycosphingolipid metabolism;Sphingolipid metabolism
(Consensus)
Recessive Scores
- pRec
- 0.158
Intolerance Scores
- loftool
- 0.136
- rvis_EVS
- -1.04
- rvis_percentile_EVS
- 7.8
Haploinsufficiency Scores
- pHI
- 0.122
- hipred
- N
- hipred_score
- 0.408
- ghis
- 0.551
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.352
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Arsi
- Phenotype
Gene ontology
- Biological process
- Cellular component
- extracellular region;endoplasmic reticulum lumen
- Molecular function
- arylsulfatase activity;protein binding;metal ion binding